Cyclerion Therapeutics Inc (CYCN)
2.84
-0.12
(-3.89%)
USD |
NASDAQ |
May 06, 16:00
2.85
+0.01
(+0.35%)
After-Hours: 20:00
Cyclerion Therapeutics Price to Book Value: 0.6818 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 0.6818 |
| May 03, 2024 | 0.7095 |
| May 02, 2024 | 0.677 |
| May 01, 2024 | 0.7299 |
| April 30, 2024 | 0.6794 |
| April 29, 2024 | 0.7395 |
| April 26, 2024 | 0.7035 |
| April 25, 2024 | 0.7299 |
| April 24, 2024 | 0.665 |
| April 23, 2024 | 0.7323 |
| April 22, 2024 | 0.7323 |
| April 19, 2024 | 0.8403 |
| April 18, 2024 | 0.7726 |
| April 17, 2024 | 0.7726 |
| April 16, 2024 | 0.7635 |
| April 15, 2024 | 0.7971 |
| April 12, 2024 | 0.8091 |
| April 11, 2024 | 0.7322 |
| April 10, 2024 | 0.7443 |
| April 09, 2024 | 0.7227 |
| April 08, 2024 | 0.7683 |
| April 05, 2024 | 0.7923 |
| April 04, 2024 | 0.8139 |
| April 03, 2024 | 0.7587 |
| April 02, 2024 | 0.7587 |
| Date | Value |
|---|---|
| April 01, 2024 | 0.7371 |
| March 28, 2024 | 0.7683 |
| March 27, 2024 | 0.7395 |
| March 26, 2024 | 0.7395 |
| March 25, 2024 | 0.7275 |
| March 22, 2024 | 0.7323 |
| March 21, 2024 | 0.7683 |
| March 20, 2024 | 0.7923 |
| March 19, 2024 | 0.7443 |
| March 18, 2024 | 0.7683 |
| March 15, 2024 | 0.7803 |
| March 14, 2024 | 0.8067 |
| March 13, 2024 | 0.7227 |
| March 12, 2024 | 0.7203 |
| March 11, 2024 | 0.7447 |
| March 08, 2024 | 0.7515 |
| March 07, 2024 | 0.7443 |
| March 06, 2024 | 0.6722 |
| March 05, 2024 | 0.6959 |
| March 04, 2024 | 0.7683 |
| March 01, 2024 | 0.7599 |
| February 29, 2024 | 0.7203 |
| February 28, 2024 | 0.6817 |
| February 27, 2024 | 0.6422 |
| February 26, 2024 | 0.6356 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3628
Minimum
Nov 15 2023
4.812
Maximum
Mar 31 2023
1.668
Average
1.594
Median
Aug 05 2019
Price to Book Value Benchmarks
| Eli Lilly and Co | 56.87 |
| iBio Inc | 0.7539 |
| AbbVie Inc | 35.89 |
| Agile Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.008 |
Price to Book Value Related Metrics
| PS Ratio | 12.39 |
| Price | 2.84 |
| Earnings Yield | -106.0% |
| Market Cap | 7.697M |